Cite
Wingerter A, El Malki K, Sandhoff R, et al. Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma. Cancers (Basel). 2021;13(3)doi: 10.3390/cancers13030520.
Wingerter, A., El Malki, K., Sandhoff, R., Seidmann, L., Wagner, D. C., Lehmann, N., Vewinger, N., Frauenknecht, K. B. M., Sommer, C. J., Traub, F., Kindler, T., Russo, A., Otto, H., Lollert, A., Staatz, G., Roth, L., Paret, C., & Faber, J. (2021). Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma. Cancers, 13(3), . https://doi.org/10.3390/cancers13030520
Wingerter, Arthur, et al. "Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma." Cancers vol. 13,3 (2021). doi: https://doi.org/10.3390/cancers13030520
Wingerter A, El Malki K, Sandhoff R, Seidmann L, Wagner DC, Lehmann N, Vewinger N, Frauenknecht KBM, Sommer CJ, Traub F, Kindler T, Russo A, Otto H, Lollert A, Staatz G, Roth L, Paret C, Faber J. Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma. Cancers (Basel). 2021 Jan 29;13(3). doi: 10.3390/cancers13030520. PMID: 33572900; PMCID: PMC7866294.
Copy
Download .nbib